Glucose Range Monitoring System
SFU is the FDA product code for Glucose Range Monitoring System, a class II device type, regulated under 21 CFR 862.1359. FDA's definition for this code reads: "A glucose range monitoring system (GRM) is intended to automatically measure glucose in the body and provide qualitative or semi-quantitative information about glucose levels or trends continuously or frequently. GRM systems are intended to support general user awareness of glucose ranges related to glycemic control...". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.
Classification record
- Product code
- SFU
- Device name
- Glucose Range Monitoring System
- FDA definition
- A glucose range monitoring system (GRM) is intended to automatically measure glucose in the body and provide qualitative or semi-quantitative information about glucose levels or trends continuously or frequently. GRM systems are intended to support general user awareness of glucose ranges related to glycemic control. Outputs from GRM systems do not represent quantitative glucose concentration values and GRM systems are not intended to be used for acute medical decision-making, such as insulin dosing or medication adjustment.
- Regulation
- 21 CFR 862.1359
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 2
- Ingested recalls
- 0
Clearances, product code SFU
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2025 | 1 |
| 2026 | 1 |
Applicants with the most clearances
Product code SFU| Applicant | Clearances |
|---|---|
| Biolinq Incorporated | 1 |
| Biolinq Incorporated | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
